Valuation: AstraZeneca PLC

Market Cap 295B 258B 239B 220B 418B 28,201B 426B 2,859B 1,113B 13,828B 1,108B 1,084B 47,981B P/E 2026 *
23.8x
P/E 2027 * 20.9x
Enterprise Value 314B 275B 254B 235B 446B 30,047B 454B 3,046B 1,185B 14,733B 1,180B 1,155B 51,121B EV / Sales 2026 *
4.98x
EV / Sales 2027 * 4.59x
Free-Float
96.63%
Yield 2026 *
1.75%
Yield 2027 * 1.85%

Last Transcript: AstraZeneca PLC

1 day-0.86%
1 week+0.99%
Current month+0.99%
1 month+2.76%
3 months-4.80%
6 months+0.11%
Current year+3.26%
1 week 13,894
Extreme 13894
14,686
1 month 11,484
Extreme 11484
15,126
Current year 11,232
Extreme 11232
15,732
1 year 10,178
Extreme 10178
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,029
Extreme 8029
15,732
10 years 3,996
Extreme 3996
15,732
Manager TitleAgeSince
Chief Executive Officer 66 2012-09-30
Director of Finance/CFO 52 2021-07-31
Compliance Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 70 1999-04-05
Director/Board Member 66 2012-09-30
Director/Board Member 65 2017-04-26
Date Insider Type Main position Quantity % Market Cap.
Jun. 07Free

See Remarks

1 0.0000%
May. 19Sell

See Remarks

-11,893 0.0008%
May. 13Fiscal year

Chief Executive Officer

18,359 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
-0.86%+0.99%+39.36%+40.85% 298B
-1.60%+1.37%+57.31%+168.94% 1,102B
-1.44%+3.71%+69.64%+65.40% 643B
-0.75%+0.44%+34.70%+86.52% 450B
-1.35%+0.63%+30.26%+26.28% 336B
-0.71%-0.54%+28.98%+48.27% 288B
-1.31%+2.72%-26.76%-39.82% 222B
-0.03%+1.62%+25.62%+68.30% 199B
-0.40%+7.50%+21.51%+82.50% 169B
-0.08%-0.12%-4.71%-32.31% 137B
Average -0.67%+2.22%+27.59%+51.49% 384.32B
Weighted average by Cap. -0.39%+2.06%+40.58%+82.30%

Financials

2026 *2027 *
Net sales 63.19B 55.33B 51.07B 47.18B 89.53B 6,037B 91.15B 612B 238B 2,960B 237B 232B 10,271B 66.84B 58.53B 54.03B 49.91B 94.71B 6,386B 96.42B 647B 252B 3,131B 251B 245B 10,865B
Net income 12.45B 10.9B 10.07B 9.3B 17.64B 1,190B 17.96B 121B 46.94B 583B 46.74B 45.73B 2,024B 13.96B 12.23B 11.28B 10.43B 19.78B 1,334B 20.14B 135B 52.62B 654B 52.4B 51.27B 2,269B
Net Debt 19.32B 16.92B 15.62B 14.43B 27.37B 1,846B 27.87B 187B 72.82B 905B 72.51B 70.95B 3,140B 11.81B 10.34B 9.54B 8.82B 16.73B 1,128B 17.03B 114B 44.51B 553B 44.32B 43.37B 1,920B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
26-07-08 GBX 14,240.00 -0.86% 1,480,149
26-07-07 GBX 14,364.00 +1.87% 1,528,247
26-07-06 GBX 14,100.00 -2.46% 2,008,204
26-07-03 GBX 14,456.00 -0.56% 653,264
26-07-02 GBX 14,538.00 +4.94% 2,810,574
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
190.30USD
Average target price
217.01USD
Spread / Average Target
+14.04%

Quarterly revenue - Rate of surprise